CYTOMEGALOVIRUS (CMV)
Clinical trials for CYTOMEGALOVIRUS (CMV) explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS (CMV) trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS (CMV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World check on transplant virus drug
Disease control Recruiting nowThis study aims to see how the drug maribavir is used and how well it works for controlling cytomegalovirus (CMV) infections in adults who have had a transplant. Researchers will follow about 75 patients in Belgium for up to 2 years, collecting data from their regular doctor visi…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New oral drug trial targets dangerous virus in vulnerable cancer patients
Disease control Recruiting nowThis study is testing whether an oral antiviral drug called maribavir can safely and effectively control cytomegalovirus (CMV) infections in patients with multiple myeloma or lymphoma. These patients are receiving a newer type of cancer treatment (bispecific antibodies) that can …
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Kidney transplant breakthrough: weekly blood tests could replace daily Anti-Viral pills
Disease control Recruiting nowThis study compares two approaches to prevent CMV infection in kidney transplant patients who receive an organ from a CMV-positive donor. One group takes daily antiviral medication for 200 days, while the other group gets weekly blood tests for 100 days and only takes medication …
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug monitored for Tough-to-Treat virus in transplant patients
Disease control Recruiting nowThis study is monitoring the use of Maribavir tablets in Japan for patients who have received an organ or stem cell transplant and developed a Cytomegalovirus (CMV) infection that hasn't responded to other treatments. The main goals are to check how well the drug works to clear t…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New transplant drug under Real-World watch in korea
Disease control Recruiting nowThis study is monitoring the safety and effectiveness of the approved drug LIVTENCITY (maribavir) when used in routine medical practice. It will follow 168 adults in South Korea who have a difficult-to-treat CMV infection after an organ or stem cell transplant. The goal is to col…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New hope for transplant patients fighting Drug-Resistant virus
Disease control Recruiting nowThis study is testing an oral drug called maribavir in Chinese adults who have had a transplant and have a cytomegalovirus (CMV) infection that has not responded to standard antiviral treatments. The main goals are to see how safe the drug is, how well patients tolerate it, and i…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Researchers look back at safety of CMV drug in vulnerable kidney patients
Knowledge-focused Recruiting nowThis study aims to check the safety of the drug maribavir in adults who have had an organ or stem cell transplant, have a difficult-to-treat cytomegalovirus (CMV) infection, and also have severe kidney disease or kidney failure. Researchers will look at the existing medical recor…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC